We are live on ! Find out more
KA

Kozak & Associates Portfolio holdings

AUM $576M
1-Year Est. Return 23.37%
This Fund
S&P 500
This Quarter Est. Return
+17.25%
1 Year Est. Return
+23.37%
3 Year Est. Return
+97.43%
5 Year Est. Return
+117.62%
10 Year Est. Return
AUM
$576M
AUM Growth
+$63.3M
Cap. Flow
+$15.9M
Cap. Flow %
2.76%
Top 10 Hldgs %
62.9%
Holding
469
New
21
Increased
130
Reduced
70
Closed
29
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ISRG icon
276
Intuitive Surgical
ISRG
$142B
$8.45K ﹤0.01%
21
RGTI icon
277
Rigetti Computing
RGTI
$4.69B
$8.41K ﹤0.01%
450
SCHE icon
278
Schwab Emerging Markets Equity ETF
SCHE
$12.5B
$8.14K ﹤0.01%
226
HCA icon
279
HCA Healthcare
HCA
$85.6B
$8.05K ﹤0.01%
20
GSK icon
280
GSK
GSK
$106B
$7.95K ﹤0.01%
155
ACGL icon
281
Arch Capital
ACGL
$35B
$7.79K ﹤0.01%
79
SLYG icon
282
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$5.1B
$7.74K ﹤0.01%
65
QS icon
283
QuantumScape Corp
QS
$3.64B
$7.61K ﹤0.01%
1,000
HSBC icon
284
HSBC
HSBC
$345B
$7.57K ﹤0.01%
79
FSSL
285
FS Specialty Lending Fund
FSSL
$835M
$7.37K ﹤0.01%
+657
New +$7.76K
MMM icon
286
3M
MMM
$84.4B
$7.26K ﹤0.01%
45
BMY icon
287
Bristol-Myers Squibb
BMY
$124B
$7.07K ﹤0.01%
125
-162
-56% -$9.3K
FNDC icon
288
Schwab Fundamental International Small Company Index ETF
FNDC
$3.02B
$7.04K ﹤0.01%
145
+1
+0.7% +$49
CVS icon
289
CVS Health
CVS
$136B
$6.9K ﹤0.01%
66
+1
+2% +$89
HPQ icon
290
HP
HPQ
$22.1B
$6.82K ﹤0.01%
310
+2
+0.6% +$44
SQM icon
291
Sociedad Química y Minera de Chile
SQM
$18.9B
$6.68K ﹤0.01%
90
VRTX icon
292
Vertex Pharmaceuticals
VRTX
$123B
$6.47K ﹤0.01%
13
BBWI icon
293
Bath & Body Works
BBWI
$4.26B
$6.36K ﹤0.01%
284
+3
+1% +$57
WBD icon
294
Warner Bros
WBD
$68.4B
$6.35K ﹤0.01%
237
-32
-12% -$866
MCK icon
295
McKesson
MCK
$98.5B
$6.14K ﹤0.01%
8
SNX icon
296
TD Synnex
SNX
$19.5B
$5.91K ﹤0.01%
23
RH icon
297
RH
RH
$3.58B
$5.74K ﹤0.01%
35
VFC icon
298
VF Corp
VFC
$6.86B
$5.71K ﹤0.01%
339
+2
+0.6% +$36
LYG icon
299
Lloyds Banking Group
LYG
$87.6B
$5.61K ﹤0.01%
951
SNA icon
300
Snap-on
SNA
$21.5B
$5.6K ﹤0.01%
14

Similar funds

Kozak & Associates's Q2 2026 Portfolio in Review

As of Q2 2026, Kozak & Associates held 469 positions worth $576M, up 12% from $513M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Kozak & Associates's Q2 2026 filing shows 21 new, 130 increased, 70 reduced and 29 closed positions. Its largest new stake was PGIM Jennison Focused Value ETF: 258,669 shares worth $25.3M. The largest sale was Invesco S&P 500 Revenue ETF, an estimated $31.4M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

  • Kozak & Associates's largest Q2 2026 buy was PGIM Jennison Focused Value ETF: 258,669 shares worth $25.3M.
  • Kozak & Associates added most to iShares S&P Mid-Cap 400 Growth ETF in Q2 2026, an estimated $24M increase.
  • Kozak & Associates's biggest Q2 2026 reduction was Invesco S&P 500 Revenue ETF, cutting an estimated $31.4M.
  • Kozak & Associates fully exited Agnico Eagle Mines in Q2 2026, selling an estimated $217K.
  • Kozak & Associates's ten largest holdings make up 63% of its $576M portfolio in Q2 2026.
  • Kozak & Associates opened 21 new positions and closed 29 in Q2 2026.
  • Kozak & Associates's portfolio value rose 12% quarter-over-quarter to $576M.

Based on Kozak & Associates's 13F filing for Q2 2026, filed 2 Jul 2026.